By Professor Andrew Stewart Day

Journal articles

Day AS; Adamji M, 2017, 'Commentary: Impact of fecal calprotectin measurement on decision-making in children with inflammatory bowel disease', Frontiers in Pediatrics, 5, http://dx.doi.org/10.3389/fped.2017.00133

Alhagamhmad MH; Lemberg DA; Day AS; Tan LZ; Ooi CY; Krishnan U; Gupta N; Munday JS; Leach ST, 2017, 'Advancing nutritional therapy: A novel polymeric formulation attenuates intestinal inflammation in a murine colitis model and suppresses pro-inflammatory cytokine production in ex-vivo cultured inflamed colonic biopsies', Clinical Nutrition, 36, pp. 497 - 505, http://dx.doi.org/10.1016/j.clnu.2016.01.010

Bowden MR; Ee LC; Krishnan U; O'Loughlin EV; Hardikar W; Carmody D; Hainsworth C; Jermyn V; Lee MM; Sawyer J; Stormon M; Holmes K; Lemberg DA; Day AS; Paul C; Hazell P, 2017, 'Family impact and infant emotional outcomes following diagnosis of serious liver disease or transplantation in infancy', Journal of Pediatric Gastroenterology and Nutrition, 64, pp. 528 - 532, http://dx.doi.org/10.1097/MPG.0000000000001404

Budd GR; Aitchison A; Day AS; Keenan JI, 2017, 'The effect of polymeric formula on enterocyte differentiation', Innate Immunity, 23, pp. 240 - 248, http://dx.doi.org/10.1177/1753425916689333

Alhagamhmad MH; Day AS; Lemberg DA; Leach ST, 2017, 'Exploring and enhancing the anti-inflammatory properties of polymeric formula', Journal of Parenteral and Enteral Nutrition, 41, pp. 436 - 445, http://dx.doi.org/10.1177/0148607115625627

Lopez RN; Leach ST; Lemberg DA; Duvoisin G; Gearry RB; Day AS, 2017, 'Fecal biomarkers in inflammatory bowel disease', Journal of Gastroenterology and Hepatology (Australia), 32, pp. 577 - 582, http://dx.doi.org/10.1111/jgh.13611

Nightingale S; Stormon MO; O'Loughlin EV; Shun A; Thomas G; Benchimol EI; Day AS; Adams S; Shi E; Ooi CY; Kamath BM; Fecteau A; Langer JC; Roberts EA; Ling SC; Ng VL, 2017, 'Early Posthepatoportoenterostomy Predictors of Native Liver Survival in Biliary Atresia', Journal of Pediatric Gastroenterology and Nutrition, 64, pp. 203 - 209, http://dx.doi.org/10.1097/MPG.0000000000001289

Chae A; Aitchison A; Day AS; Keenan JI, 2017, 'Bovine colostrum demonstrates anti-inflammatory and antibacterial activity in in vitro models of intestinal inflammation and infection', Journal of Functional Foods, 28, pp. 293 - 298, http://dx.doi.org/10.1016/j.jff.2016.11.016

Duvoisin G; Lopez RN; Day AS; Lemberg DA; Gearry RB; Leach ST, 2017, 'Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease', Mediators of Inflammation, 2017, pp. 1936315, http://dx.doi.org/10.1155/2017/1936315

Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY, 2017, 'Age-Dependent Values of Fecal Calprotectin in Cystic Fibrosis and Healthy Controls', Gastroenterology, 152, pp. S645 - S645, http://dx.doi.org/10.1016/s0016-5085(17)32281-3

Garg M; Leach ST; Needham B; Coffey MJ; Katz T; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY, 2017, 'Determining the Age-Related Levels of Fecal M2-Pyruvate Kinase in Children with Cystic Fibrosis During the First Decade of Life', Gastroenterology, 152, pp. S645 - S646, http://dx.doi.org/10.1016/s0016-5085(17)32282-5

Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY, 2017, 'EPS3.1 Age-dependent values of fecal calprotectin in cystic fibrosis and healthy children', Journal of Cystic Fibrosis, 16, pp. S41 - S41, http://dx.doi.org/10.1016/s1569-1993(17)30292-8

Garg M; Leach ST; Needham B; Coffey MJ; Katz TE; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY, 2017, 'WS21.1 Determining the age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis during the first decade of life', Journal of Cystic Fibrosis, 16, pp. S34 - S34, http://dx.doi.org/10.1016/s1569-1993(17)30268-0

Alhagamhmad MH; Day AS; Lemberg DA; Leach ST, 2016, 'An overview of the bacterial contribution to Crohn disease pathogenesis', Journal of Medical Microbiology, 65, pp. 1049 - 1059, http://dx.doi.org/10.1099/jmm.0.000331

Su HY; Gupta V; Day AS; Gearry RB, 2016, 'Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand', Inflammatory Bowel Diseases, 22, pp. 2238 - 2244, http://dx.doi.org/10.1097/MIB.0000000000000829

Kaakoush NO; Thomas DS; Ruzayqat MM; Lynch D; Leach ST; Lemberg DA; Day AS; Mitchell HM, 2016, 'Campylobacter concisus utilizes blood but not short chain fatty acids despite showing associations with firmicutes taxa', Microbiology (United Kingdom), 162, pp. 1388 - 1397, http://dx.doi.org/10.1099/mic.0.000328

Kaakoush NO; Thomas DS; Ruzayqat MM; Lynch D; Leach ST; Lemberg DA; Day AS; Mitchell HM, 2016, 'Campylobacter concisus utilizes blood but not short chain fatty acids despite showing associations with Firmicutes taxa', MICROBIOLOGY-SGM, 162, pp. 1388 - 1397, http://dx.doi.org/10.1099/mic.0.000328

De Voogd FAE; Gearry RB; Mulder CJ; Day AS, 2016, 'Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma', Journal of Gastroenterology and Hepatology (Australia), 31, pp. 1386 - 1392, http://dx.doi.org/10.1111/jgh.13324

Kaakoush NO; Day AS; Leach ST; Lemberg DA; Mitchell HM, 2016, 'Reduction in Gut Microbial Diversity as a Mechanism of Action of Exclusive Enteral Nutrition', American Journal of Gastroenterology, 111, pp. 1033, http://dx.doi.org/10.1038/ajg.2016.61

Nielsen S; Needham B; Leach ST; Day AS; Jaffe A; Thomas T; Ooi CY, 2016, 'Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis', Scientific Reports, 6, pp. 24857, http://dx.doi.org/10.1038/srep24857

Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB, 2016, 'Comparison of fecal inflammatory markers in Crohn's disease', Inflammatory Bowel Diseases, 22, pp. 1086 - 1094, http://dx.doi.org/10.1097/MIB.0000000000000671

Andre M; Day AS, 2016, 'Causes of prolonged jaundice in infancy: 3-year experience in a tertiary paediatric centre', New Zealand Medical Journal, 129, pp. 14 - 21

Karim S; McCombie A; Day AS; Gearry RB, 2016, '797 Transition Clinics in Inflammatory Bowel Disease: An Observational Study of Patients' Attitude, Views and Concerns', Gastroenterology, 150, pp. S167 - S167, http://dx.doi.org/10.1016/s0016-5085(16)30652-7

Leach ST; Lui K; Naing Z; Dowd SE; Mitchell HM; Day AS, 2015, 'Multiple Opportunistic Pathogens, but Not Pre-existing Inflammation, May Be Associated with Necrotizing Enterocolitis', Digestive Diseases and Sciences, 60, pp. 3728 - 3734, http://dx.doi.org/10.1007/s10620-015-3830-6

Kho A; Whitehead M; Day AS, 2015, 'Coeliac disease in children in Christchurch, New Zealand: Presentation and patterns from 2000-2010.', World J Clin Pediatr, 4, pp. 148 - 154, http://dx.doi.org/10.5409/wjcp.v4.i4.148

Boon GJAM; Day AS; Mulder CJ; Gearry RB, 2015, 'Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?', World Journal of Gastroenterology, 21, pp. 11469 - 11480, http://dx.doi.org/10.3748/wjg.v21.i40.11469

Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A, 2015, 'Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?', Digestive Diseases and Sciences, 60, pp. 2946 - 2952, http://dx.doi.org/10.1007/s10620-015-3842-2

Eliadou E; Day AS; Thompson-Fawcett MW; Gearry RB; Rowbotham DS; Walmsley R; Schultz M; Inns SJ, 2015, 'New Zealand society of gastroenterology guidelines for the management of refractory ulcerative colitis', New Zealand Medical Journal, 128, pp. 63 - 76

Shepherd D; Day AS; Leach ST; Lopez R; Messenger R; Woodhead HJ; Ledder O; Lemberg DA, 2015, 'Single high-dose oral Vitamin D3 therapy (Stoss): A solution to Vitamin D deficiency in children with inflammatory bowel disease?', Journal of Pediatric Gastroenterology and Nutrition, 61, pp. 411 - 414, http://dx.doi.org/10.1097/MPG.0000000000000823

Nahidi L; Corley SM; Wilkins MR; Wei J; Alhagamhmad M; Day AS; Lemberg DA; Leach ST, 2015, 'The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis', Genes and Nutrition, 10, http://dx.doi.org/10.1007/s12263-015-0479-x

Moeeni V; Shojaee P; Kianifar H; Walls T; Pattemore P; Day AS, 2015, 'The Prospective Assessment of Nutrition in Children with Cystic Fibrosis', International Journal of Child Health and Nutrition, 4, pp. 129 - 134, http://dx.doi.org/10.6000/1929-4247.2015.04.03.1

Day AS; Lopez RN, 2015, 'Exclusive enteral nutrition in children with crohn's disease', World Journal of Gastroenterology, 21, pp. 6809 - 6816, http://dx.doi.org/10.3748/wjg.v21.i22.6809

Bowden MR; Stormon M; Hardikar W; Ee LC; Krishnan U; Carmody D; Jermyn V; Lee MM; O'Loughlin EV; Sawyer J; Beyerle K; Lemberg DA; Day AS; Paul C; Hazell P, 2015, 'Family adjustment and parenting stress when an infant has serious liver disease: The Australian experience', Journal of Pediatric Gastroenterology and Nutrition, 60, pp. 717 - 722, http://dx.doi.org/10.1097/MPG.0000000000000742

Day AS, 2015, 'Inflammatory bowel disease and the intestinal microbiota', Journal of Pediatric Biochemistry, 5, pp. 60 - 64, http://dx.doi.org/10.1055/s-0035-1564576

Lopez RN; Day AS, 2015, 'Feeding the Infant at High-Risk of Celiac Disease – An Update', Frontiers in Pediatrics, 3, http://dx.doi.org/10.3389/fped.2015.00047

Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY, 2015, 'Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: A clue to the increased risk of intestinal malignancy in adulthood?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30, pp. 866 - 871, http://dx.doi.org/10.1111/jgh.12842

Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB, 2015, 'Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery', Gastroenterology, 148, pp. 938 - 947.e1, http://dx.doi.org/10.1053/j.gastro.2015.01.026

Tye-Din JA; Cameron DJS; Daveson AJ; Day AS; Dellsperger P; Hogan C; Newnham ED; Shepherd SJ; Steele RH; Wienholt L; Varney MD, 2015, 'Appropriate clinical use of human leukocyte antigen typing for coeliac disease: An Australasian perspective', Internal Medicine Journal, 45, pp. 441 - 450, http://dx.doi.org/10.1111/imj.12716

Ledder O; Lemberg DA; Day AS, 2015, 'Thiopurine-induced pancreatitis in inflammatory bowel diseases', Expert Review of Gastroenterology and Hepatology, 9, pp. 399 - 403, http://dx.doi.org/10.1586/17474124.2015.992879

Degraeuwe PLJ; Beld MPA; Ashorn M; Canani RB; Day AS; Diamanti A; Fagerberg UL; Henderson P; Kolho KL; Van De Vijver E; Van Rheenen PF; Wilson DC; Kessels AGH, 2015, 'Faecal calprotectin in suspected paediatric inflammatory bowel disease', Journal of Pediatric Gastroenterology and Nutrition, 60, pp. 339 - 346, http://dx.doi.org/10.1097/MPG.0000000000000615

Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB, 2015, 'Disease activity assessment in IBD: Clinical indices and biomarkers fail to predict endoscopic remission', Inflammatory Bowel Diseases, 21, pp. 824 - 831, http://dx.doi.org/10.1097/MIB.0000000000000341

Lemberg DA; Day AS, 2015, 'Crohn disease and ulcerative colitis in children: An update for 2014', Journal of Paediatrics and Child Health, 51, pp. 266 - 270, http://dx.doi.org/10.1111/jpc.12685

Flores SE; Day AS; Keenan JI, 2015, 'Measurement of total iron in Helicobacter pylori-infected gastric epithelial cells', BioMetals, 28, pp. 143 - 150, http://dx.doi.org/10.1007/s10534-014-9810-z

Kaakoush NO; Day AS; Leach ST; Lemberg DA; Nielsen S; Mitchell HM, 2015, 'Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease', Clinical and Translational Gastroenterology, 6, http://dx.doi.org/10.1038/ctg.2014.21

Kaakoush NO; Castaño-Rodríguez N; Day AS; Lemberg DA; Leac ST; Mitchell HM, 2015, 'Faecal levels of zonula occludens toxin in paediatric patients with crohn’s disease and their association with the intestinal microbiota', Journal of Medical Microbiology, 64, pp. 303 - 306, http://dx.doi.org/10.1099/jmm.0.000005

Alhagamhmad M; Leach S; Day AS; Lemberg D, 2015, 'Mo1231 Attenuation of Intestinal Inflammation by Co-Supplementation of Glutamine and Arginine', Gastroenterology, 148, pp. S - 644, http://dx.doi.org/10.1016/s0016-5085(15)32176-4

Alhagamhmad M; Leach S; Day AS; Lemberg D, 2015, 'Mo1232 Development of an Enhanced Nutritional Therapy for the Treatment of Crohn's Disease', Gastroenterology, 148, pp. S - 644, http://dx.doi.org/10.1016/s0016-5085(15)32177-6

Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A, 2015, 'Su1367 Faecal Human Beta-Defensin 2 Levels in Children With Cystic Fibrosis', Gastroenterology, 148, pp. S - 487, http://dx.doi.org/10.1016/s0016-5085(15)31638-3

Wright EK; De Cruz P; Gearry R; Day AS; Kamm MA, 2014, 'Fecal biomarkers in the diagnosis and monitoring of Crohn's disease', Inflammatory Bowel Diseases, 20, pp. 1668 - 1677, http://dx.doi.org/10.1097/MIB.0000000000000087

Wall CL; Gearry RB; Day AS, 2014, 'Polymeric formula is more palatable than elemental formula to adults with Crohn's disease', e-SPEN Journal, 9, pp. e200 - e203, http://dx.doi.org/10.1016/j.clnme.2014.08.003

Back to profile page